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Summary.-Specific substances binding [3H]-triamcinolone acetonide have been
demonstrated in the cytoplasmic fraction of the R3230AC mammary carcinoma using
sucrose gradient centrifugation. These receptors, which exhibit sedimentation
coefficients of 8-9 Svedberg units, are relatively specific for glucocorticoid ligands
and possess a high affinity for triamcinolone acetonide (Kd a 7 x 10-8 mol/l).
THE R3230AC mammary tumour is a
well differentiated adenocarcinoma of the
rat which has retained many ofthe charac-
teristics of the lactating mammary gland.
Significant levels of certain enzymes
involved in carbohydrate and lipid meta-
bolism are present (Hilf et al., 1965) as
well as detectable quantities of several
gland specific substances such as lactose
and casein-like proteins in the oestrogen
stimulated state (Hilf, 1967). Theenzyme
responsible for the synthesis of lactose,
lactose synthetase, has also been found
(McGuire, 1969; Turkington and Riddle,
1969). The R3230AC tumour, which has
been classified as an oestrogen responsive
neoplasm (Hilf, 1971 ), also containsspecific
oestrogen binding proteins (Wittliff et al.,
1972a). Although similar in many res-
pects, on a quantitative scale the R3230AC
tumour is deficient compared with the
lactating mammary gland in virtually
every biochemical parameter chosen.
Recently, our laboratory demonstrated
the presence of a specific receptor for
glucocorticoids in the cytosol of lactating
mammary gland ofthe rat (Gardner, 1972).
These data and the previous observation
by Hilf et al. (1965) that administration
ofhydrocortisone to the host inhibited the
growth ofthe R3230AC tumour, prompted
an examination of this neoplasm for
similar glucocorticoid binding proteins. A
preliminarycharacterization oftheserecep-
tors is presented in this communication.
MATERIALS AND METHODS
Intact female rats (Fischer strain 344,
wAeighing 80-90 g) were implanted with
R3230AC tumour cells using a sterile trocar
technique and then sacrificed by cervical
dislocation at various times after transplan-
tation. Tumours were removed during the
period of exponential growth, usually at
20-25 days (Wittliff et al., 1972a). Tumour
tissue was homogenized in an appropriate
volume of cold 10 mmol/l Tris HCI, pH 7 4,
containing 1 a mmol/l EDTA and centrifuged
at 105,000 g (0°C) for 30 minutes to prepare
supernatant (cytosol) fraction.
The assay for the glucocorticoid-binding
proteins closely paralleled that previously
employed for the oestrogen receptors in the
lactating mammary gland (Wittliff et al.,
1972a) and human breast carcinoma (Wittliff
et at., 1972b), except that [3H]-triamcinolone
acetonide (Schwarz/Mann, Orangeburg, N.Y.,
10-6 Ci/mmol) was uised as the ligand. In
each of several small shell vials, an appro-
priate amount of tritiunm-labelled steroid was
evaporated to dryness, just before assay.
To each of these vials 50 p.1 of Tris-EDTA
buffer (]0 mmol/l Tris HC'I 1 5 mmol/l ETDA.D. (X. G(ARDNER AND J. L. WITTLIFF
pH 7 4) alone, or in combination with a
precalculated quantity of unlabelled steroid
hormone or inhibitor, were added. A 200-
400 pi volume of the 103,000 g supernatant
(cytosol fraction) of tumours wNas combined
with this mixture and incubated for an
additional 60 min at 0°C to ensure formation
of the receptor-ligand complex. A 200-400
1-l portion of the total reaction volume was
layered on a linear gradient of sucrose
(5-400o). These gradients were centrifuged
for 15 hours (0°C) at 308,000 y using a Spinco
SW-56 titaniumn rotor. Following centri-
fugation, the gradient tubes were punctured
and a total of 40 fractions were collected
into scintillation vials containing 2 ml of
990 ethanol. Ten ml of toluene scintilla-
tion cocktail (4 g OmnifluorR/l toluene) were
added to eaclh fraction. The vials were then
counted in a Mark II Liquid Scintillation
Counter (Nuclear Chicago). Counting effi-
ciency (38-40%o) was then calculated through
external standardization ofindividual samples
wNith a 135Ba standard. Data wtere calcu-
lated as described elstewhere (Wittliff et al.,
1972a) and binding capacity was expressed
as fmol (10-15 mol)/mg cytosol protein.
RESULTS AND DISCUSSION
Examination of cytosols from the
R3230AC tumour revealed a single com-
ponent binding the [3H]-triamcinolone
acetonide, which sedimented in the 8-9
S region of a 5-4000 sucrose gradient
(Fig. 1). Concurrent incubation with
5 mmol/l cortexolone, a steroid shown to
be an inhibitor of glucocorticoid binding
in a thymocytes system (Munck and
Brinck-Johnsen, 1968) reduced ligand
binding to this component significantly
(Fig. 1).
The ligand binding specificity of the
glucocorticoid receptor in the tumour is
presented in Table I. The relative effect-
iveness of the competitors, each at 5
,umol/I concentration, showed the follow-
ing relationship: triamcinolone > proges-
terone > hydrocortisone > cortexolone
> oestradiol-17/. The order ofinhibition
by hydrocortisone and progesterone was
reversed at the 1 ,umol/l concentration.
The glucocorticoid receptor from lactating
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FIG. 1. I-sotopic profile of the glucocorticoid-
binding proteins ini the cytosol of the
R3230AC tumour. Supernatant obtained
from the homogenate of a tumour 25 days
post-transplantationi, was incubated with
17*5 nmol/l [3H]-triameinolonie acetonide
in the presence (dashed line) or absence
(solid line) of cortexolone (5 mmol/l.
Following the incubation, each mixture was
layered on a 5-400% sucrose gradient and
centrifuged at 308,000 g for 15 hours. The
glucocorticoid-biniding substance sedi-
mented at a rate comparable with that
of the specific oestrogen-receptor from the
mammary gland, i.e., 8-9 Svedbergs
(WVittliffet al., 1972a).
mammary gland exhibited similar binding
properties (Gardner, 1972). Oestradiol-
17/ was without effect at the 1 ,umol/I
concentration but lowered binding by 500%
at the 5 ,mmol/l level. Cortexolone was
relatively ineffective at the 1 ,umol/l con-
centration, surpassing only oestradiol.
However, at a concentration of 5 jumol/l,
it inhibited the binding of [3H]-triamcino-
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TABLE I.-Steroid Specificity of the Glucocorticoid-binding Protein In the R3230AC
Mammary Tumour*
Competitive substance Concentration (x 10-6 mol/l)
None
Triamcinolone 5
Triamcinolone 1
Cortexolone 5
Cortexolone 1
Hydrocortisone 5
Hydrocortisone 1
Oestradiol-17,B 5
Oestradiol-17fl 1
Progesterone 5
Progesterone 1
[3H]-Triamcinolone
acetonide bound (%)
100
8
14
25
66
13
41
45
91
20
34
* Supernatants from R3230AC tumours were incubated with 10 nmol/l [3H]-triamcinolone acetonide,
alone or in combination with the concentration of unlabelled steroid designated. Following incubation at
0°C for 1 hour the mixtures were layered on 5-40% sucrose gradients and centrifuged at 308,000 g for 15
hours. Total binding was determined as the radioactivity bound in the 8-9 S region of the gradient. Com-
petition is expressed as % of total binding in the untreated (control) gradient. The competition studies
using th6,5 ,umol/l concentrations ofsteroid were run on a 27-day old tumour; the studies using the 1 ,mol/l
concentrations on a 25-day old tumour.
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FIG. 2.-Scatchard analysis of titration data
for the glucocorticoid-binding proteins in
the cytosol of the R3230AC tumour. A
constant volume of supernatant prepared
from a mammary tumour was incubated
withincreasingconcentrationsof[3H]-triam-
cinolone acetonide. The binding capacity
was estimated as the radioactivity bound in
the 8 S region of the gradients. The slope
of the line is equal to - 1/Kd, where Kd is
the dissociation constant of the triamcino-
lone-receptor complex. The value of Kd
obtained from this plot is 6-6 x 10-8
mol/l.
lone acetonide to the receptor sedimenting
at 8-9 S (Fig. 1, Table I). Although
triamcinolone (1 ,umol/l) was an efficient
competitor for glucocorticoid binding sites,
it did not inhibit the binding of [3H]-
oestradiol-17p to the oestrogen-receptor
in lactating mammary gland (Gardner,
1972).
Like the receptor from lactating mam-
mary gland, the glucocorticoid binding
protein in the tumour had a relatively
high affinity for its steroid ligand. Scat-
chard analysis (Scatchard, 1949) of the
titration data (Fig. 2) provided a dissocia-
tion constant (Kd) = 6-6 x 10-8M), which
is in the same range as that ofthe receptor
from the lactating mammary gland (Gard-
ner, 1972). The number of binding sites/
mg cytosol protein was calculated as
100 fmol. This is approximately ten-fold
less than measured in the cytosol of the
lactating mammarygland (Gardner, 1972).
The demonstration of a cytoplasmic
8 S receptor for triamcinolone acetonide
with ligand specificities and steroid affinity
similar to that of the gJucocorticoid
binding protein in the lactating mammary
gland serves to reinforce the parallels
previously drawn between this neoplastic
tissue and its normal counterpart (Hilf
et al., 1965; Hilf, 1967, 1971; McGuire,
-444 D). (G GARDNER AND J. L. WITTLIF1P
1969; Turkington and Riddle, 1969;
Wittliff et al., 1972a). As with most other
biochemical parameters chosen for com-
parison, levels of the glucocorticoid bind-
ing protein are substantially less thanthose
seen in the lactating gland.
This represents the first report of a
specific glucocorticoid receptor in a rodent
mammary carcinoma. Furthermore, the
presence of these receptors offers a
plausible mode of action for the glucocor-
ticoid-mediated inhibition of tumour
growth as well as alterations in certain
enzyme activities which these hormones
reportedly bring about (Hilf et al., 1965).
Thus, the glucocorticoid receptor offers
yet another basis for comparison between
the lactating mammary gland and the
R3230AC mammary adenocarcinoma.
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